|
|
See Category: Diseases of the nervous system
See Header: Lennox-Gastaut syndrome
ICD-10 (CM) Code and Descriptor
|
G40.813 |
Lennox-Gastaut syndrome, intractable, with status epilepticus
|
G40813 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 58.96%
|
15.99%
|
9.27%
|
5.40%
|
2.85%
|
2.55%
|
2.65%
|
0.61%
|
0.41%
|
0.10%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for G40.813*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
184
|
185
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
164
|
165
|
|
80053
|
COMPREHEN METABOLIC PANEL |
126
|
126
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
117
|
118
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
97
|
98
|
|
80164
|
ASSAY DIPROPYLACETIC ACD TOT |
59
|
61
|
|
G0480
|
DRUG TEST DEF 1-7 CLASSES |
47
|
47
|
|
85027
|
COMPLETE CBC AUTOMATED |
45
|
45
|
|
80175
|
DRUG SCREEN QUAN LAMOTRIGINE |
43
|
43
|
|
J1580
|
GARAMYCIN GENTAMICIN INJ |
41
|
59
|
|
80048
|
METABOLIC PANEL TOTAL CA |
41
|
41
|
|
83735
|
ASSAY OF MAGNESIUM |
38
|
40
|
|
97530
|
THERAPEUTIC ACTIVITIES |
33
|
58
|
|
82140
|
ASSAY OF AMMONIA |
31
|
31
|
|
97110
|
THERAPEUTIC EXERCISES |
30
|
38
|
|
80177
|
DRUG SCRN QUAN LEVETIRACETAM |
26
|
26
|
|
51798
|
US URINE CAPACITY MEASURE |
26
|
26
|
|
97140
|
MANUAL THERAPY 1/> REGIONS |
25
|
37
|
|
J2060
|
LORAZEPAM INJECTION |
25
|
60
|
|
82306
|
VITAMIN D 25 HYDROXY |
24
|
24
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
G40.813 related to the following DRG Codes:
023
100-101
|
